Novel ABHD12 Mutations in PHARC Patients

Hidekane Yoshimura, Takao Hashimoto, Toshinori Murata, Kunihiro Fukushima, Akiko Sugaya, Shin Ya Nishio, Shin Ichi Usami

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Objective: This study examines ABHD12 mutation analysis in 2 PHARC patients, originally thought to be Usher syndrome. Methods: The ABHD12 gene of 2 patients, who suffered from deaf-blindness and dysfunctional central and peripheral nervous systems, were sequenced. Results: We identified that both cases carried the same novel splice site mutation in the ABHD12 gene. However, 1 had epilepsy and the other had peripheral neuropathy. Based on haplotype analysis, the mutation is likely not a hot spot, but rather could be attributable to a common ancestor. Conclusion: This study shows that PHARC has phenotypic variability, even within a family, which is consistent with previous reports. Differential diagnosis of "deaf-blindness" diseases is crucial. Confirming the presence of associated symptoms is necessary for differentiating some deaf-blindness syndromes. In addition, mutation analysis is a useful tool for confirming the diagnosis.

Original languageEnglish
Pages (from-to)77S-83S
JournalAnnals of Otology, Rhinology and Laryngology
Volume124
Issue number1_suppl
DOIs
Publication statusPublished - May 1 2015

Fingerprint

Blindness
Mutation
Usher Syndromes
Peripheral Nervous System
Peripheral Nervous System Diseases
Haplotypes
Genes
Epilepsy
Differential Diagnosis
Central Nervous System

Keywords

  • ABHD12
  • deaf-blindness
  • genetics of hearing loss
  • PHARC
  • Usher syndrome

ASJC Scopus subject areas

  • Otorhinolaryngology
  • Medicine(all)

Cite this

Yoshimura, H., Hashimoto, T., Murata, T., Fukushima, K., Sugaya, A., Nishio, S. Y., & Usami, S. I. (2015). Novel ABHD12 Mutations in PHARC Patients. Annals of Otology, Rhinology and Laryngology, 124(1_suppl), 77S-83S. https://doi.org/10.1177/0003489415574513

Novel ABHD12 Mutations in PHARC Patients. / Yoshimura, Hidekane; Hashimoto, Takao; Murata, Toshinori; Fukushima, Kunihiro; Sugaya, Akiko; Nishio, Shin Ya; Usami, Shin Ichi.

In: Annals of Otology, Rhinology and Laryngology, Vol. 124, No. 1_suppl, 01.05.2015, p. 77S-83S.

Research output: Contribution to journalArticle

Yoshimura, H, Hashimoto, T, Murata, T, Fukushima, K, Sugaya, A, Nishio, SY & Usami, SI 2015, 'Novel ABHD12 Mutations in PHARC Patients', Annals of Otology, Rhinology and Laryngology, vol. 124, no. 1_suppl, pp. 77S-83S. https://doi.org/10.1177/0003489415574513
Yoshimura H, Hashimoto T, Murata T, Fukushima K, Sugaya A, Nishio SY et al. Novel ABHD12 Mutations in PHARC Patients. Annals of Otology, Rhinology and Laryngology. 2015 May 1;124(1_suppl):77S-83S. https://doi.org/10.1177/0003489415574513
Yoshimura, Hidekane ; Hashimoto, Takao ; Murata, Toshinori ; Fukushima, Kunihiro ; Sugaya, Akiko ; Nishio, Shin Ya ; Usami, Shin Ichi. / Novel ABHD12 Mutations in PHARC Patients. In: Annals of Otology, Rhinology and Laryngology. 2015 ; Vol. 124, No. 1_suppl. pp. 77S-83S.
@article{e454d4c2c14643378a28edfc05214ef5,
title = "Novel ABHD12 Mutations in PHARC Patients",
abstract = "Objective: This study examines ABHD12 mutation analysis in 2 PHARC patients, originally thought to be Usher syndrome. Methods: The ABHD12 gene of 2 patients, who suffered from deaf-blindness and dysfunctional central and peripheral nervous systems, were sequenced. Results: We identified that both cases carried the same novel splice site mutation in the ABHD12 gene. However, 1 had epilepsy and the other had peripheral neuropathy. Based on haplotype analysis, the mutation is likely not a hot spot, but rather could be attributable to a common ancestor. Conclusion: This study shows that PHARC has phenotypic variability, even within a family, which is consistent with previous reports. Differential diagnosis of {"}deaf-blindness{"} diseases is crucial. Confirming the presence of associated symptoms is necessary for differentiating some deaf-blindness syndromes. In addition, mutation analysis is a useful tool for confirming the diagnosis.",
keywords = "ABHD12, deaf-blindness, genetics of hearing loss, PHARC, Usher syndrome",
author = "Hidekane Yoshimura and Takao Hashimoto and Toshinori Murata and Kunihiro Fukushima and Akiko Sugaya and Nishio, {Shin Ya} and Usami, {Shin Ichi}",
year = "2015",
month = "5",
day = "1",
doi = "10.1177/0003489415574513",
language = "English",
volume = "124",
pages = "77S--83S",
journal = "Annals of Otology, Rhinology and Laryngology",
issn = "0003-4894",
publisher = "Annals Publishing Company",
number = "1_suppl",

}

TY - JOUR

T1 - Novel ABHD12 Mutations in PHARC Patients

AU - Yoshimura, Hidekane

AU - Hashimoto, Takao

AU - Murata, Toshinori

AU - Fukushima, Kunihiro

AU - Sugaya, Akiko

AU - Nishio, Shin Ya

AU - Usami, Shin Ichi

PY - 2015/5/1

Y1 - 2015/5/1

N2 - Objective: This study examines ABHD12 mutation analysis in 2 PHARC patients, originally thought to be Usher syndrome. Methods: The ABHD12 gene of 2 patients, who suffered from deaf-blindness and dysfunctional central and peripheral nervous systems, were sequenced. Results: We identified that both cases carried the same novel splice site mutation in the ABHD12 gene. However, 1 had epilepsy and the other had peripheral neuropathy. Based on haplotype analysis, the mutation is likely not a hot spot, but rather could be attributable to a common ancestor. Conclusion: This study shows that PHARC has phenotypic variability, even within a family, which is consistent with previous reports. Differential diagnosis of "deaf-blindness" diseases is crucial. Confirming the presence of associated symptoms is necessary for differentiating some deaf-blindness syndromes. In addition, mutation analysis is a useful tool for confirming the diagnosis.

AB - Objective: This study examines ABHD12 mutation analysis in 2 PHARC patients, originally thought to be Usher syndrome. Methods: The ABHD12 gene of 2 patients, who suffered from deaf-blindness and dysfunctional central and peripheral nervous systems, were sequenced. Results: We identified that both cases carried the same novel splice site mutation in the ABHD12 gene. However, 1 had epilepsy and the other had peripheral neuropathy. Based on haplotype analysis, the mutation is likely not a hot spot, but rather could be attributable to a common ancestor. Conclusion: This study shows that PHARC has phenotypic variability, even within a family, which is consistent with previous reports. Differential diagnosis of "deaf-blindness" diseases is crucial. Confirming the presence of associated symptoms is necessary for differentiating some deaf-blindness syndromes. In addition, mutation analysis is a useful tool for confirming the diagnosis.

KW - ABHD12

KW - deaf-blindness

KW - genetics of hearing loss

KW - PHARC

KW - Usher syndrome

UR - http://www.scopus.com/inward/record.url?scp=84939456564&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84939456564&partnerID=8YFLogxK

U2 - 10.1177/0003489415574513

DO - 10.1177/0003489415574513

M3 - Article

C2 - 25743180

AN - SCOPUS:84939456564

VL - 124

SP - 77S-83S

JO - Annals of Otology, Rhinology and Laryngology

JF - Annals of Otology, Rhinology and Laryngology

SN - 0003-4894

IS - 1_suppl

ER -